Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06558708
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-14
Brief Title:
A Trial Comparing Efficacy Tolerability and Safety of GZR101 Injection Once Daily OD and GZR33-70 Injection OD
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase II Trial Comparing Efficacy Tolerability and Safety of GZR101 Injection and GZR33-70 Injection in Type 2 Diabetes Inadequately Controlled on Basal Insulin or Premixed Insulin Once Daily at Least With or Without Pre-dinner Meal-time Insulin
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is conducted in China The aim of the trial is to compare the efficacy tolerability and safety of GZR101 Injection and GZR33-70 Injection in type 2 diabetes inadequately controlled on basal premixed insulin once daily at least with or without pre-dinner meal-time insulin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None